Back to results
US 2024/0285650 A1Published application
NON-HORMONAL STEROID MODULATORS OF NF-kB FOR TREATMENT OF DISEASE
AssigneeReveraGen BioPharma, Inc.
InventorsJohn M. MCCALL, Eric HOFFMAN, Kanneboyina NAGARAJU
Life of this patent
Estimating the term…
Abstract
The present invention relates to compounds and methods which may be useful as treatments of neuromuscular diseases such as muscular dystrophy, and as inhibitors of NF-κB for the treatment or prevention of muscular wasting disease, including muscular dystrophy.
Claims8
1-54. (canceled)
A pharmaceutical composition comprising a therapeutically effective amount of compound having a structural formula
- in a tablet or a capsule form,
- wherein the pharmaceutical composition further comprises at least one excipient chosen from binders, inert diluents, lubricating agents, surface active agents, and dispersing agents.
Dependencies are inferred from the claim text.